Skip to main content
. 2021 Jan 14;13(2):286. doi: 10.3390/cancers13020286

Figure 5.

Figure 5

Association of type of progressive disease (HPD vs. non-HPD) with OS of chemotherapy after immunotherapy failure (OS chemo).